Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Pai.ACT: AI-powered chatbot-assisted ACT for parents of children with neurodevelopmental disorders

Official title: Artificial Intelligence-driven, Chatbot-assisted Acceptance and Commitment Therapy (Pai.ACT) for Parents of Young Children With Neurodevelopmental Disorders: A Randomised Controlled Trial

Run by Chinese University of Hong Kong · NCT06779422 · Data updated 2026-11-12

This trial tests a chatbot-guided ACT program for Cantonese-speaking parents of young children with neurodevelopmental disorders to see if it helps reduce parenting stress and improves family well-being.

More Neurodevelopmental Disorders trials

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment210 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedSeptember 10, 2026
Trial IDNCT06779422 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Cantonese-speaking parents of 2–6 year-olds with NDD (ASD, ADHD, or developmental delay) living in Hong Kong, who are comfortable using a smartphone and are not currently enrolled in other psychosocial interventions.

Probably not a fit

Parents with severe mental health conditions, significant cognitive/language barriers, or those already participating in other psychosocial programs may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses an AI-driven chatbot to deliver personalized Acceptance and Commitment Therapy strategies to primary caregivers of children aged 2–6 with neurodevelopmental disorders. It aims to address parental anxiety and depression while enhancing psychological flexibility and parenting practices. Participants are Cantonese-speaking, Hong Kong residents who live with their child, own a smartphone, and meet DSM-5-based criteria for their child’s NDD diagnosis. The intervention seeks to be scalable and accessible beyond traditional in-person formats, targeting outcomes for both parents and children. The trial is conducted under institutional oversight by Chinese University of Hong Kong with collaboration from local social welfare and service organizations.

Why it matters

Potential benefit: If successful, parents may experience reduced stress and improved mental health, potentially benefiting child development and family functioning.

How similar studies have gone: Previous studies suggest ACT-based approaches can help parents of children with developmental challenges, but virtual or AI-guided formats remain relatively novel and still require robust validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primary caregivers who are Cantonese-speaking Hong Kong residents.
* Parents aged ≥21 years.
* Primary caregivers who adopt the responsibility of taking care of the child.
* Living together with the child and having smartphone devices for daily access to the internet.
* Parent's children should be with following criteria:

  i) Aged 2-6 years. ii) Received a primary and clinical diagnosis/suspected diagnosis of NDD as indicated in the clinical records according to the DSM-5 criteria. (e.g., ASD, ADHD, developmental delay) iii) Registered for Social Welfare Department subvented Onsite Pre-school Rehabilitation Services.

Exclusion Criteria:

* Parents diagnosed with severe mental illnesses.
* Parents with learning, cognitive, language, communication impairments or other debilitating conditions. (e.g., hearing or vision impairment) that could impede full participation in the study)
* Parents currently participating in /under the evaluation of other psychosocial, psychoeducation or parenting programmes.

Where it's running

  • The Chinese University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.